Skip to main content
. Author manuscript; available in PMC: 2013 Jul 18.
Published in final edited form as: Cancer Prev Res (Phila). 2009 Mar 31;2(4):370–376. doi: 10.1158/1940-6207.CAPR-08-0209

Fig. 1.

Fig. 1

Immunohistochemical analysis of bronchial biopsies from smokers (including 31 dysplastic and 67 hyperplastic/metaplastic sites). A, photomicrographs showing representative immunohistochemical staining for P-Akt (T308) and P-ERK (T202/Y204) in normal lung (top) and dysplastic lesions (bottom). B, percentage of lesions positive for P-Akt (T308) and P-ERK (T202/Y204). C, association between activated Akt and ERK in hyperplastic/metaplastic and dysplastic lesions.

HHS Vulnerability Disclosure